Report cover image

Terumo Corp (4543) - Product Pipeline Analysis, 2023 Update

Publisher GlobalData
Published Jul 26, 2023
Length 103 Pages
SKU # GBDT18100617

Description

North America Flat Glass Market Summary, Competitive Analysis and Forecast to 2027


Summary

Flat Glass in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • Flat glass is typically used for windows and other applications, including glass tables and doors. It is also known as plate glass and sheet glass. By end-use, the market is segmented into building & construction, automotive, and others. The scope of others segment includes electronics, solar PV, and furniture.
  • The North American flat glass market had total revenues of $18.1 billion in 2022, representing a compound annual growth rate (CAGR) of 2.3% between 2017 and 2022.
  • Market consumption volume increased with a CAGR of 2.3% between 2017 and 2022, to reach a total of 12 million Tons in 2022.
  • The volume of the flat glass in the market witnessed an increase of 4.6% in 2022 as compared to 4.4% in 2021. Increasing growth in the automotive industry is the underlying factor driving the global flat glass market growth.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the flat glass market in North America
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the flat glass market in North America
  • Leading company profiles reveal details of key flat glass market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the North America flat glass market with five year forecasts
Reasons to Buy
  • What was the size of the North America flat glass market by value in 2022?
  • What will be the size of the North America flat glass market in 2027?
  • What factors are affecting the strength of competition in the North America flat glass market?
  • How has the market performed over the last five years?
  • What are the main segments that make up North America's flat glass market?

Table of Contents

103 Pages
Terumo Corp Company Overview
Terumo Corp Company Snapshot
Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview
Terumo Corp – Pipeline Analysis Overview
Business Description
Terumo Corp - Key Facts
Terumo Corp - Major Products and Services
Terumo Corp Pipeline Products by Development Stage
Terumo Corp Ongoing Clinical Trials by Trial Status
Terumo Corp Pipeline Products Overview
Advanced Coil
Advanced Coil Product Overview
Advanced WEB Aneurysm Embolization Device
Advanced WEB Aneurysm Embolization Device Product Overview
AI-Based Percutaneous Coronary Intervention System
AI-Based Percutaneous Coronary Intervention System Product Overview
AortaFit System
AortaFit System Product Overview
AortaFit System Clinical Trial
Atherectomy Device
Atherectomy Device Product Overview
Balloon Guide Catheter
Balloon Guide Catheter Product Overview
BoulEVARd Stent
BoulEVARd Stent Product Overview
CMOS Image Glucose Sensor
CMOS Image Glucose Sensor Product Overview
Coated Stent
Coated Stent Product Overview
Coil Assist Stent
Coil Assist Stent Product Overview
Cross-Seal System
Cross-Seal System Product Overview
Digital Healthcare Support System
Digital Healthcare Support System Product Overview
Digital Therapy Support System
Digital Therapy Support System Product Overview
Fineglide
Fineglide Product Overview
Flash PTCA
Flash PTCA Product Overview
FRED X
FRED X Product Overview
Hybrid Stent Graft
Hybrid Stent Graft Product Overview
Infusion Pump
Infusion Pump Product Overview
Izanai
Izanai Product Overview
Kaitoh Atherectomy System
Kaitoh Atherectomy System Product Overview
Kaitoh Atherectomy System Clinical Trial
Kenma
Kenma Product Overview
Large Volume Injector
Large Volume Injector Product Overview
Liver Cancer Ablation System
Liver Cancer Ablation System Product Overview
Mirasol Pathogen Reduction Technology System - Platelets & Plasma
Mirasol Pathogen Reduction Technology System - Platelets & Plasma Product Overview
Mirasol Pathogen Reduction Technology System - Whole Blood
Mirasol Pathogen Reduction Technology System - Whole Blood Product Overview
MISAGO RX Self-Expanding Stent System
MISAGO RX Self-Expanding Stent System Product Overview
MISAGO RX Self-Expanding Stent System Clinical Trial
Nesaku
Nesaku Product Overview
Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold
Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold Product Overview
Next Ultimaster Metallic Drug Eluting Stent
Next Ultimaster Metallic Drug Eluting Stent Product Overview
Ophthalmic Needle
Ophthalmic Needle Product Overview
Optimal Dosing System
Optimal Dosing System Product Overview
Opuswave
Opuswave Product Overview
Plasmapheresis Device
Plasmapheresis Device Product Overview
Plastic Needle
Plastic Needle Product Overview
QuiremSpheres
QuiremSpheres Product Overview
QuiremSpheres Clinical Trial
QuiremSpheres - Brain Tumor
QuiremSpheres - Brain Tumor Product Overview
QuiremSpheres - Pancreatic Tumor
QuiremSpheres - Pancreatic Tumor Product Overview
QuiremSpheres - Pancreatic Tumor Clinical Trial
Radial Access Closure Device
Radial Access Closure Device Product Overview
RelayBranch Thoracic Stent-Graft System
RelayBranch Thoracic Stent-Graft System Product Overview
RelayBranch Thoracic Stent-Graft System Clinical Trial
RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection
RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Product Overview
RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection Clinical Trial
RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury
RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury Product Overview
Renal Sympathetic Denervation System - TRI Technique
Renal Sympathetic Denervation System - TRI Technique Product Overview
Robotic Surgical Support Device
Robotic Surgical Support Device Product Overview
Runner PTCA Balloon Catheter
Runner PTCA Balloon Catheter Product Overview
Runner Slim PTCA
Runner Slim PTCA Product Overview
Smartphone-Type Device - MEDISAFE WITH
Smartphone-Type Device - MEDISAFE WITH Product Overview
Structural Heart Disease Device
Structural Heart Disease Device Product Overview
TERUMO Surshield-PUR Safety I.V. Catheter
TERUMO Surshield-PUR Safety I.V. Catheter Product Overview
TF Press
TF Press Product Overview
Thoracoabdominal Hybrid Device
Thoracoabdominal Hybrid Device Product Overview
TREOVANCE Abdominal Stent Graft With Navitel Delivery System
TREOVANCE Abdominal Stent Graft With Navitel Delivery System Product Overview
TREOVANCE Abdominal Stent Graft With Navitel Delivery System Clinical Trial
Ultimaster Nagomi
Ultimaster Nagomi Product Overview
Ultimaster Nagomi Clinical Trial
Wrist Artery Guidewire
Wrist Artery Guidewire Product Overview
Terumo Corp - Key Competitors
Terumo Corp - Key Employees
Terumo Corp - Key Employee Biographies
Terumo Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Terumo Corp, Recent Developments
May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
Mar 13, 2023: Terumo prospective registry reinforces safety, efficacy and efficiency of radial access in visceral interventions (R.A.V.I.) in embolization procedures
Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
Jan 25, 2023: Terumo and Siemens Healthineers India collaborate to strengthen cardiac care in India
Dec 28, 2022: Inspira Technologies signs strategic OEM agreement with Terumo Cardiovascular
Nov 10, 2022: Terumo Corp Announces Consolidated Financial Results for the Second Quarter Ended September 30, 2022
Nov 01, 2022: New randomized controlled study published in JAMA demonstrates the value of clinical decision support tools in preventing acute kidney injury in patients undergoing coronary angiography
Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021
Oct 21, 2021: Terumo Blood and Cell Technologies opens manufacturing facility in Costa Rica
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Terumo Corp Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Terumo Corp Pipeline Products by Equipment Type
Table 3: Terumo Corp Pipeline Products by Indication
Table 4: Terumo Corp, Key Facts
Table 5: Terumo Corp, Major Products and Services
Table 6: Terumo Corp Number of Pipeline Products by Development Stage
Table 7: Terumo Corp Pipeline Products Summary by Development Stage
Table 8: Terumo Corp Ongoing Clinical Trials by Trial Status
Table 9: Terumo Corp Ongoing Clinical Trials Summary
Table 10: Advanced Coil - Product Status
Table 11: Advanced Coil - Product Description
Table 12: Advanced WEB Aneurysm Embolization Device - Product Status
Table 13: Advanced WEB Aneurysm Embolization Device - Product Description
Table 14: AI-Based Percutaneous Coronary Intervention System - Product Status
Table 15: AI-Based Percutaneous Coronary Intervention System - Product Description
Table 16: AortaFit System - Product Status
Table 17: AortaFit System - Product Description
Table 18: AortaFit System - Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study
Table 19: Atherectomy Device - Product Status
Table 20: Atherectomy Device - Product Description
Table 21: Balloon Guide Catheter - Product Status
Table 22: Balloon Guide Catheter - Product Description
Table 23: BoulEVARd Stent - Product Status
Table 24: BoulEVARd Stent - Product Description
Table 25: CMOS Image Glucose Sensor - Product Status
Table 26: CMOS Image Glucose Sensor - Product Description
Table 27: Coated Stent - Product Status
Table 28: Coated Stent - Product Description
Table 29: Coil Assist Stent - Product Status
Table 30: Coil Assist Stent - Product Description
Table 31: Cross-Seal System - Product Status
Table 32: Cross-Seal System - Product Description
Table 33: Digital Healthcare Support System - Product Status
Table 34: Digital Healthcare Support System - Product Description
Table 35: Digital Therapy Support System - Product Status
Table 36: Digital Therapy Support System - Product Description
Table 37: Fineglide - Product Status
Table 38: Fineglide - Product Description
Table 39: Flash PTCA - Product Status
Table 40: Flash PTCA - Product Description
Table 41: FRED X - Product Status
Table 42: FRED X - Product Description
Table 43: Hybrid Stent Graft - Product Status
Table 44: Hybrid Stent Graft - Product Description
Table 45: Infusion Pump - Product Status
Table 46: Infusion Pump - Product Description
Table 47: Izanai - Product Status
Table 48: Izanai - Product Description
Table 49: Kaitoh Atherectomy System - Product Status
Table 50: Kaitoh Atherectomy System - Product Description
Table 51: Kaitoh Atherectomy System - Kaitoh Atherectomy System: Peripheral Artery Revascularization of Stenotic/Restenotic Disease Using the Atherectomy System in the Peripheral Arteries
Table 52: Kenma - Product Status
Table 53: Kenma - Product Description
Table 54: Large Volume Injector - Product Status
Table 55: Large Volume Injector - Product Description
Table 56: Liver Cancer Ablation System - Product Status
Table 57: Liver Cancer Ablation System - Product Description
Table 58: Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Status
Table 59: Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Description
Table 60: Mirasol Pathogen Reduction Technology System - Whole Blood - Product Status
Table 61: Mirasol Pathogen Reduction Technology System - Whole Blood - Product Description
Table 62: MISAGO RX Self-Expanding Stent System - Product Status
Table 63: MISAGO RX Self-Expanding Stent System - Product Description
Table 64: MISAGO RX Self-Expanding Stent System - Occlusive/Stenotic Peripheral Artery Revascularization Study for Common And/Or External ILIAC Artery using the Misago Rx Self-expanding Peripheral Stent:OSPREY ILIAC
Table 65: Nesaku - Product Status
Table 66: Nesaku - Product Description
Table 67: Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold - Product Status
Table 68: Next Generation Ultimaster Drug Eluting Bioresorbable Scaffold - Product Description
Table 69: Next Ultimaster Metallic Drug Eluting Stent - Product Status
Table 70: Next Ultimaster Metallic Drug Eluting Stent - Product Description
Table 71: Ophthalmic Needle - Product Status
Table 72: Ophthalmic Needle - Product Description
Table 73: Optimal Dosing System - Product Status
Table 74: Optimal Dosing System - Product Description
Table 75: Opuswave - Product Status
Table 76: Opuswave - Product Description
Table 77: Plasmapheresis Device - Product Status
Table 78: Plasmapheresis Device - Product Description
Table 79: Plastic Needle - Product Status
Table 80: Plastic Needle - Product Description
Table 81: QuiremSpheres - Product Status
Table 82: QuiremSpheres - Product Description
Table 83: QuiremSpheres - Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
Table 84: QuiremSpheres - Clinical Validation of a Fractional Administration Device for Holmium-166 Microspheres During Selective Internal Radiation Therapy in Patients With Liver Tumours
Table 85: QuiremSpheres - Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma; a Prospective, Single-arm, Open Label, Multicenter Phase II Study: HOMIE-166
Table 86: QuiremSpheres - Brain Tumor - Product Status
Table 87: QuiremSpheres - Brain Tumor - Product Description
Table 88: QuiremSpheres - Pancreatic Tumor - Product Status
Table 89: QuiremSpheres - Pancreatic Tumor - Product Description
Table 90: QuiremSpheres - Pancreatic Tumor - Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Center, Non-randomized, Feasibility Study in an Open Surgical Setting - The SLOTH1 Study
Table 91: QuiremSpheres - Pancreatic Tumor - Percutaneous Intratumoural Holmium Microspheres Brachytherapy for Patients with Pancreatic Cancer; A Single Centre, Prospective Safety and Feasibility Study
Table 92: Radial Access Closure Device - Product Status
Table 93: Radial Access Closure Device - Product Description
Table 94: RelayBranch Thoracic Stent-Graft System - Product Status
Table 95: RelayBranch Thoracic Stent-Graft System - Product Description
Table 96: RelayBranch Thoracic Stent-Graft System - A Prospective, Multicenter, Non-blinded, Non-randomized Early Feasibility Study of the Relay Branch Thoracic Stent-graft System in Subjects with Thoracic Aortic Pathologies Requiring Treatment Proximal to the Origin of the Innominate Artery
Table 97: RelayBranch Thoracic Stent-Graft System - Cerebral Hemodynamics and Microemboli During Placement of RelayBranch Thoracic Stent-Graft System
Table 98: RelayBranch Thoracic Stent-Graft System - ENDOBARC-S Study: Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain
Table 99: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Status
Table 100: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Product Description
Table 101: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - A Prospective, Multi-center, Non-blinded, Non-randomized Study of the RelayPro Thoracic Stent-graft in Subjects with an Acute, Complicated Type B Aortic Dissection
Table 102: RelayPro Thoracic Stent-Graft System - Acute Complicated Type B Thoracic Aortic Dissection - Thoraflex Hybrid and Relay Extension Post-Approval Study
Table 103: RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Status
Table 104: RelayPro Thoracic Stent-Graft System - Blunt Traumatic Aortic Injury - Product Description
Table 105: Renal Sympathetic Denervation System - TRI Technique - Product Status
Table 106: Renal Sympathetic Denervation System - TRI Technique - Product Description
Table 107: Robotic Surgical Support Device - Product Status
Table 108: Robotic Surgical Support Device - Product Description
Table 109: Runner PTCA Balloon Catheter - Product Status
Table 110: Runner PTCA Balloon Catheter - Product Description
Table 111: Runner Slim PTCA - Product Status
Table 112: Runner Slim PTCA - Product Description
Table 113: Smartphone-Type Device - MEDISAFE WITH - Product Status
Table 114: Smartphone-Type Device - MEDISAFE WITH - Product Description
Table 115: Structural Heart Disease Device - Product Status
Table 116: Structural Heart Disease Device - Product Description
Table 117: TERUMO Surshield-PUR Safety I.V. Catheter - Product Status 7
Table 118: TERUMO Surshield-PUR Safety I.V. Catheter - Product Description 7
Table 119: TF Press - Product Status
Table 120: TF Press - Product Description
Table 121: Thoracoabdominal Hybrid Device - Product Status
Table 122: Thoracoabdominal Hybrid Device - Product Description
Table 123: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Product Status
Table 124: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Product Description
Table 125: TREOVANCE Abdominal Stent Graft With Navitel Delivery System - Anatomical Feasibility of an Off-the-shelf Scalloped Stent-graft for Infrarenal Abdominal Aneurysm with a Hostile Neck (ReSTHoNe Study)
Table 126: Ultimaster Nagomi - Product Status
Table 127: Ultimaster Nagomi - Product Description
Table 128: Ultimaster Nagomi - A Post-Market Clinical Follow-up Study With Ultimaster Nagomi Sirolimus Eluting Coronary Stent System in Complex PCI Subjects
Table 129: Wrist Artery Guidewire - Product Status
Table 130: Wrist Artery Guidewire - Product Description
Table 131: Terumo Corp, Key Employees
Table 132: Terumo Corp, Key Employee Biographies
Table 133: Terumo Corp, Other Locations
Table 134: Terumo Corp, Subsidiaries
Table 135: Glossary
List of Figures
Figure 1: Terumo Corp Pipeline Products by Equipment Type
Figure 2: Terumo Corp Pipeline Products by Development Stage
Figure 3: Terumo Corp Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us